How effective are tocolytics in the management of retained placenta in order to reduce the need for manual removal of the placenta?
This review was based on a single, small study. Another limitation of the study was that retained placenta was not specified as detached or non-detached. There is no evidence available for other types of tocolytics.
Retained placenta affects 0.5% to 3% of women following delivery, with considerable morbidity, and possible mortality, if left untreated. Use of tocolytics (uterine relaxants), either alone or in combination with uterotonics, may be of value to minimise the need for manual removal of the placenta in theatre under anaesthesia.